Holdings of B Group, Inc.
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 19 in 3 countries
- Top ten
- 84.1 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | ADMA Biologics Inc | 3,207,542 | 28.9M $ | |
| 2 | Palisade Bio Inc | 11,414,285 | 20M $ | |
| 3 | Praxis Precision Medicines Inc | 33,237 | 10.7M $ | |
| 4 | CELLECTIS SA | 3,281,501 | 10.4M $ | |
| 5 | ZAI LAB LTD | 450,646 | 8.5M $ | |
| 6 | Taysha Gene Therapies Inc | 1,800,556 | 8M $ | |
| 7 | NRX PHARMACEUTICALS INC | 3,000,000 | 6.4M $ | |
| 8 | STRUCTURE THERAPEUTICS INC | 127,500 | 6.1M $ | |
| 9 | Iovance Biotherapeutics Inc | 1,500,000 | 5.3M $ | |
| 10 | Spyre Therapeutics Inc | 100,000 | 5M $ | |
| 11 | ASSEMBLY BIOSCIENCES INC | 175,706 | 4.9M $ | |
| 12 | Aura Biosciences Inc | 597,576 | 4M $ | |
| 13 | ORUKA THERAPEUTICS INC | 75,000 | 3.7M $ | |
| 14 | Sight Sciences Inc | 970,000 | 3.7M $ | |
| 15 | Ultragenyx Pharmaceutical Inc | 135,000 | 2.8M $ | |
| 16 | Apogee Therapeutics Inc | 7,500 | 631.3K $ | |
| 17 | Foghorn Therapeutics Inc | 102,000 | 487.6K $ | |
| 18 | Soleno Therapeutics Inc | 7,500 | 251.1K $ | |
| 19 | Replimune Group Inc | 26,000 | 198.9K $ |
Sector breakdown
- Unattributed 100.0 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 85.5 %
- France 8.0 %
- Cayman Islands 6.5 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 17 | 111.1M $ | 85.47 % |
| 2 | France | 1 | 10.4M $ | 8.00 % |
| 3 | Cayman Islands | 1 | 8.5M $ | 6.52 % |
Cite this page
Titelia. "Holdings of B Group, Inc.". https://titelia.com/en/funds/US13F2043476